Jones Day, Brown Rudnick Aid Hologic In $3.7B Gen-Probe Buy
The Bedford, Mass.-based buyer expects the deal to draw earnings of as high as 20 cents per share in the first fiscal year after closing the deal closes, which Hologic said should happen in the second half of 2012 after Gen-Probe shareholders and regulators give their approval.
After that first-year...
Already a subscriber? Click here to login